Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy

Cold Spring Harb Perspect Biol. 2017 Oct 3;9(10):a024141. doi: 10.1101/cshperspect.a024141.

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating and rapidly progressive neurodegenerative disease caused by the deterioration of motor neurons. The first symptoms of ALS always begin at a focal but variable site and consistently spread to neighboring regions, suggesting that neurodegeneration in ALS is an orderly and propagating process. Like other neurodegenerative diseases, misfolding of a specific protein is central to ALS. SOD1, the major constituent of the protein deposits in some familial and sporadic forms of ALS, propagates its misfolded conformation like prions, providing a plausible molecular basis for the focality and spreading of muscle weakness in ALS. Because protein misfolding is a common cause of diverse neurodegenerative diseases, strategies aimed at boosting a cell's ability to cope with misfolded proteins could lead to therapeutics to combat these devastating age-related proteinopathies.

Publication types

  • Review

MeSH terms

  • Amyotrophic Lateral Sclerosis / metabolism*
  • Amyotrophic Lateral Sclerosis / therapy
  • Humans
  • Prions / metabolism*
  • Superoxide Dismutase-1 / metabolism*

Substances

  • Prions
  • SOD1 protein, human
  • Superoxide Dismutase-1